本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enanta Pharmaceuticals Inc.

12.96
+0.26002.05%
盤後12.960.00000.00%19:30 EDT
成交量:28.91萬
成交額:372.10萬
市值:3.76億
市盈率:-5.53
高:13.04
開:12.83
低:12.59
收:12.70
52周最高:17.15
52周最低:7.05
股本:2,901.85萬
流通股本:2,251.30萬
量比:1.27
換手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-2.3416
每股收益(LYR):-3.8381
淨資產收益率:-70.12%
總資產收益率:-12.28%
市淨率:3.72
市盈率(LYR):-3.38

資料載入中...

2022/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

重要事件披露

8-K - Current report
2022/03/08

重要事件披露

8-K - Current report
2022/02/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/08

重要事件披露

8-K - Current report
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/17

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/12/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/23

持股變動聲明

4 - Statement of changes in beneficial ownership of securities